Dr. Sanjay Prasad is on a mission to improve surgical outcomes. After many years as a surgeon, he’s founded SurgiQuality, a company that helps patients find the best surgeon for their condition and avoid surgeries they don’t need. He’s also laser focused on reducing racial disparities in surgical care. And he’s written a handbook for patients: Resetting Healthcare Post-COVID-19 Pandemic.
In this episode of the HealthBiz podcast, Dr. Prasad describes him immigrant roots, what made him decide to become a doctor, and how he developed insights about what’s wrong with surgery and how to fix it.
James MacKay grew up in Scotland, and was encouraged by his father to pursue a career in business –but not the family business. Instead he earned a PhD in genetics and began a long stint with AstraZeneca, eventually jumping across the pond and all the way to San Diego. He continued with A companies like Ardea an now Arthrosi and Aristea, where he’s even done a deal with Arena.
In this episode of the HealthBiz podcast James talks about how he and his team at Aristea Therapeutics are applying their decades of experience to develop a drug they licensed from AstraZeneca. The first indication is PPP –no not purchasing power parity or the paycheck protection program– but palmoplantar pustulosis, a nasty illness with no good treatments today. We talk about why good drugs get left on the shelf at big pharma, and the future of the biotech industry and San Diego.
Mike Rea is a self-professed bad scientist and bad musician but despite –and perhaps even because– of those limitations, he’s built some pretty good companies.
As CEO of IDEA Pharma and Protodigm, he makes a distinction between the invention of a drug in the lab and the level of innovation in its development. Although he compares the work to that of a CRO, he clarifies that it’s really a bit upstream from there. And in the future, if you hear Protodigm start talking about being a “Pre-RO,” you’ll know that little brainstorm came out of this podcast.
Mike runs a record company, aptly named Medical Records and hosts his own book club slash podcast about innovation in pharma.
Datavant is fostering an ecosystem of healthcare data to facilitate secure exchange of information and analytics that improve patient care. The company recently made headlines through a $7 Billion merger with Ciox, uniting Datavant’s world of de-identified data with Ciox’s domain expertise in patient identified records.
In this episode of the HealthBiz podcast, Datavant’s Chief Strategy Officer Jason LaBonte and Chief Operating Officer Bob Borek discuss the evolution of healthcare data, the Ciox merger, how the company has fared during the pandemic, and their long term vision.
Jason is reading Project Hail Mary by Andy Weir –whose fiction appeals to Jason’s training as a PhD scientist– and Bob likes Cadillac Desert by Marc Reisner about the history of water rights in the West.
As CTO and CIO of Solarity, Chez Tschetter enables major health systems that use Epic and Cener to share medical records with one another, efficiently and accurately. Solarity’s medical record indexing solutions use technologies like optical character recognition, natural language processing and machine learning to swiftly organize and share binders of patient information for better care. Despite what you might assume, EMRs don’t do a good job of electronically sharing information with one another. And that’s where Solarity comes in.
The pandemic has upped the ante for fast and accurate sharing of patient information, and Solarity has also figured out how to implement remotely, so it’s been all systems go since COVID’s arrival.
Chez grew up in South Dakota and likes the place so much that he’s recruited more than 100 Solarity IT staff to join him there. In this episode of the HealthBiz podcast, Chez shares his personal and business journey along with a couple of book recommendations: Where Does It hurt? by Jonathan Bush and Why We Sleep By Matthew Walker.